Hydroxyzine hydrochloride and Ingrezza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydroxyzine hydrochloride (hydroxyzine hydrochloride) and Ingrezza (valbenazine tosylate). Common drug interactions include weight decreased among females.

The phase IV clinical study analyzes what interactions people have when they take Hydroxyzine hydrochloride and Ingrezza. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Hydroxyzine hydrochloride?

Hydroxyzine hydrochloride has active ingredients of hydroxyzine hydrochloride. It is often used in stress and anxiety. eHealthMe is studying from 10,486 Hydroxyzine hydrochloride users. Check the latest studies of Hydroxyzine hydrochloride.

What is Ingrezza?

Ingrezza has active ingredients of valbenazine tosylate. eHealthMe is studying from 23,666 Ingrezza users. Check the latest studies of Ingrezza.

On Aug, 09, 2026

17 people who take Hydroxyzine hydrochloride and Ingrezza together, and have interactions are studied.

Hydroxyzine hydrochloride and Ingrezza drug interactions.

What are the common drug interactions of Hydroxyzine Hydrochloride and Ingrezza, by gender? *:

female:

Weight decreased
Dysphagia (a condition in which swallowing is difficult or painful)
Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
Speech disorder
Stomatitis (inflammation of mucous membrane of mouth)
Tardive dyskinesia (a disorder that involves involuntary movements)
Weight increased
Back pain
Blood pressure decreased
Chills (felling of cold)

male:

n/a

What are the common drug interactions of Hydroxyzine Hydrochloride and Ingrezza, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Impaired work ability
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Mood altered (changes in mood)
Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
Speech disorder
Stomatitis (inflammation of mucous membrane of mouth)
Tardive dyskinesia (a disorder that involves involuntary movements)
Weight increased
Weight decreased
Akathisia (a movement disorder characterized by a feeling of inner restlessness)

50-59:

n/a

60+:

Hypersomnia (excessive daytime sleepiness (eds))
Psychotic disorder
Urinary tract infection

What are the existing conditions these people have? *

Tardive Dyskinesia (a disorder that involves involuntary movements): 11 people, 64.71%
Depression: 5 people, 29.41%
Affective Disorder (mental disorder): 2 people, 11.76%
High Blood Pressure: 2 people, 11.76%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 11.76%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 2 people, 11.76%
Psychotic Disorder: 2 people, 11.76%
Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 11.76%
Bipolar Disorder (mood disorder): 1 person, 5.88%
Dyspnea (difficult or laboured breathing): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxyzine hydrochloride and Ingrezza?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously